SCHEMBL6662274

SCHEMBL6662274

OCC/C=C/c1cncc(Oc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.43
CHRNB4 P30926 2/20 0.43
CHRNA3 P32297 2/20 0.43
CHRNA4 P43681 2/20 0.43
CHRNA7 P36544 1/20 0.43
EPOR P19235 4/20 0.42
ALOX5 P09917 1/20 0.40
ALOX5AP P20292 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
CHRNB1 P11230 1/20 0.39
CHRNB3 Q05901 1/20 0.39
XDH P47989 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
AKT1 P31749 8/20 0.38
ROCK2 O75116 4/20 0.38
PRKACA P17612 4/20 0.38
ROCK1 Q13464 4/20 0.38
DYRK1A Q13627 4/20 0.38
PIM1 P11309 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6666536 0.82 AKT1 (0.48) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL6659993 0.82 CHRNB2 (0.66) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL31618947 0.80 LTA4H (0.48) EPORALOX5ALOX5APPTGS1PTGS2
SCHEMBL4056295 0.79 MKNK2 (0.55) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL8427305 0.78 PTGS2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL6663817 0.78 PTGS2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL4812166 0.77 ROCK2 (0.41) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL4056654 0.77 CHRNB2 (0.70) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL6660327 0.75 CHRNB2 (0.63) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL618783 0.75 CHRNB2 (0.69) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973743-B1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS TARGACEPT INC (US) 2004-08-25 EP disclosed
US-6531606-B1 Nicotinic compound: N-methyl-4-(3-(5-phenylpyridin)yl)-3-buten-1-amine; capable of affecting nicotinic chlorinergic receptors TARGACEPT, INC. 2003-03-11 US disclosed
US-6274606-B1 ADMINISTERING COMPOUNDS SUCH AS (E)-N-METHYL-4-(3-(5-ISO PROPOXYPYRIDIN)YL)-3-BUTEN-1-AMINE TO TREAT PARKINSON'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT DISORDER, SCHIZOPHRENIA, AND ALZHEIMER'S DISEASE TARGACEPT, INC. 2001-08-14 US disclosed
EP-0973743-A1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS R.J. REYNOLDS TOBACCO COMPANY (US) 2000-01-26 EP disclosed
WO-1998037071-A1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS R.J. REYNOLDS TOBACCO COMPANY (US) 1998-08-27 WO disclosed